Results 31 to 40 of about 483,790 (291)

Laboratory diagnosis of severe acute respiratory syndrome coronavirus 2 [PDF]

Pathology, 2020
The first laboratory confirmed case of Coronavirus disease 2019 (COVID-19) in Australia was in Victoria on 25 January 2020 in a man returning from Wuhan city, Hubei province, the People's Republic of China. This was followed by three cases in New South Wales the following day.
Gulholm, T., Basile, K., Kok, J., Chen, S.C.-A., Rawlinson, W.   +4 more
openaire   +4 more sources

Acute Myocarditis After Severe Acute Respiratory Syndrome Coronavirus 2 Infection

The Journal for Nurse Practitioners, 2023
This case report describes a young adult patient with post-severe acute respiratory syndrome coronavirus 2 acute viral myocarditis who initially presented to a local urgent care center. The patient decompensated and was transferred to our tertiary, intensive care setting.
LaJoie, Joan, Lentz, Brian
openaire   +2 more sources

In Utero Severe Acute Respiratory Syndrome Coronavirus 2 Infection [PDF]

Journal of the Pediatric Infectious Diseases Society, 2020
Abstract Evidence for in utero transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is growing but not definitive. We present a case of neonatal infection that supports in utero transmission of SARS-CoV-2 and provides insight into the hematogenous spread from mother to fetus.
Von Kohorn, Isabelle, Stein, Sydney R, Shikani, Beatrix T, Ramos-Benitez, Marcos J, Vannella, Kevin M, Hewitt, Stephen M, Kleiner, David E, Alejo, Julie C, Burbelo, Peter, Cohen, Jeffrey I, Wiedermann, Bernhard L, Chertow, Daniel S   +11 more
openaire   +2 more sources

Findings of Hepatic Severe Acute Respiratory Syndrome Coronavirus-2 Infection [PDF]

Cellular and Molecular Gastroenterology and Hepatology, 2021
Liver injury due to coronavirus disease 2019 (COVID-19) is being increasingly recognized. Abnormal liver chemistry tests of varying severities occur in a majority of patients. However, there is a dearth of accompanying liver histologic studies in these patients.The current report details the clinical courses of 2 patients having severe COVID-19 ...
Fiel, M. Isabel, El Jamal, Siraj M., Paniz-Mondolfi, Alberto, Gordon, Ronald E., Reidy, Jason, Bandovic, Jela, Advani, Rashmi, Kilaru, Saikiran, Pourmand, Kamron, Ward, Stephen, Thung, Swan N., Schiano, Thomas   +11 more
openaire   +3 more sources

Features associated with SARS-COV-2 positivity among people presenting with acute respiratory tract infections to public Hospitals in Harari region, Ethiopia

SAGE Open Medicine, 2021
Background: Despite investigating coronavirus among respiratory tract infected cases is a top priority to prevent further transmission, severe acute respiratory syndrome coronavirus 2 positivity among this group of patients remains unexplored in resource-
Abdi Birhanu, Galana Mamo Ayana, Miesso Bayu, Ahmed Mohammed, Yadeta Dessie   +4 more
doaj   +1 more source

Repurposing Interleukin-6 Inhibitors to Combat COVID-19. [PDF]

, 2020
Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is a pandemic with major implications across the world. One of the most frequent causes of death from SARS-CoV-2 is fatal pneumonia from coronavirus disease 2019 (COVID-19), which is associated
Kato, Shumei, Kurzrock, Razelle
core   +1 more source

Clotting disorder in severe acute respiratory syndrome coronavirus 2 [PDF]

Reviews in Medical Virology, 2020
SummaryThe severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a novel human respiratory viral infection that has rapidly progressed into a pandemic, causing significant morbidity and mortality. Blood clotting disorders and acute respiratory failure have surfaced as the major complications among the severe cases of coronavirus disease 2019 (
Pujhari, Sujit, Paul, Sanjeeta, Ahluwalia, Jasmina, Rasgon, Jason L.   +3 more
openaire   +2 more sources

Response of antibody titers to SARS-CoV-2 vaccination and clinical outcomes during the predominance of the Omicron variant in Colombia

SAGE Open Medicine, 2023
Introduction: The response to vaccination against the virus that causes severe acute respiratory infection syndrome coronavirus 2 is lower in renal transplant recipients than in the general population.
Camilo Montero, Rodolfo Torres, Maricely Reina, Jonth Flechas, David Andrade, Sebastián Moreno, Camila Granados, Nancy Yomayusa   +7 more
doaj   +1 more source

Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 [PDF]

Journal of the Pediatric Infectious Diseases Society, 2020
Abstract Over 100 attempts are being made to develop a vaccine for use in the epidemic of COVID-19. Many different technologies are being used in an effort to prevent the infection or at least the disease.
openaire   +2 more sources

Autophagy in severe acute respiratory syndrome coronavirus 2 infection

Current Opinion in Physiology, 2022
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) orchestrates host factors to remodel endomembrane compartments for various steps of the infection cycle. SARS-CoV-2 also intimately intersects with the catabolic autophagy pathway during infection.
Chen, Di, Zhang, Hong
openaire   +2 more sources